tradingkey.logo

Medtronic PLC

MDT
98.660USD
-1.210-1.21%
交易中 美東報價延遲15分鐘
126.48B總市值
26.55本益比TTM

Medtronic PLC

98.660
-1.210-1.21%

關於 Medtronic PLC 公司

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Medtronic PLC簡介

公司代碼MDT
公司名稱Medtronic PLC
上市日期Nov 21, 1977
CEOMartha (Geoffrey S)
員工數量95000
證券類型Ordinary Share
年結日Nov 21
公司地址Building Two Parkmore Business Park West
城市DUBLIN
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Ireland
郵編H91 4K49
電話1135314381700
網址https://www.medtronic.com/
公司代碼MDT
上市日期Nov 21, 1977
CEOMartha (Geoffrey S)

Medtronic PLC公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
21.71K
+0.89%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
17.64K
+0.41%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
8.19K
+0.89%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
7.39K
-81.26%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.90M
+78.68%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
548.61K
+10.51%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.34%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
49.63K
+1.73%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
48.84K
+1.86%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
40.24K
+0.18%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
其他
2.41B
28.11%
地區USD
名稱
營收
佔比
Rest of World
4.32B
50.37%
United States
4.22B
49.24%
Ireland
33.00M
0.38%
業務
地區
業務USD
名稱
營收
佔比
Cardiac Rhythm & Heart Failure
1.71B
19.96%
Surgical & Endoscopy
1.61B
18.79%
Cranial & Spinal Technologies
1.21B
14.12%
Coronary & Peripheral Vascular
930.00M
10.84%
Specialty Therapies
702.00M
8.18%
其他
2.41B
28.11%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
其他
74.57%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
10.21%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.72%
JP Morgan Asset Management
2.92%
Capital Research Global Investors
2.39%
其他
74.57%
股東類型
持股股東
佔比
Investment Advisor
46.90%
Investment Advisor/Hedge Fund
29.42%
Research Firm
4.18%
Pension Fund
2.40%
Bank and Trust
2.17%
Hedge Fund
1.41%
Sovereign Wealth Fund
1.37%
Insurance Company
0.38%
Individual Investor
0.28%
其他
11.49%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
3723
1.13B
88.20%
-2.77M
2025Q2
3762
1.12B
87.12%
-18.03M
2025Q1
3818
1.13B
88.15%
+2.18M
2024Q4
3768
1.12B
87.17%
+3.13M
2024Q3
3708
1.10B
85.63%
-24.55M
2024Q2
3725
1.11B
86.25%
-54.16M
2024Q1
3789
1.14B
85.95%
-7.87M
2023Q4
3780
1.13B
85.36%
-20.57M
2023Q3
3761
1.14B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.32M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
126.32M
9.85%
+1.88M
+1.51%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
67.84M
5.29%
-1.09M
-1.58%
Jun 30, 2025
State Street Investment Management (US)
59.83M
4.66%
-210.22K
-0.35%
Jun 30, 2025
JP Morgan Asset Management
26.31M
2.05%
-1.69M
-6.03%
Jun 30, 2025
Capital Research Global Investors
36.36M
2.83%
-5.21M
-12.53%
Jun 30, 2025
Geode Capital Management, L.L.C.
28.23M
2.2%
+310.68K
+1.11%
Jun 30, 2025
MFS Investment Management
19.36M
1.51%
-1.24M
-6.04%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
16.44M
1.28%
+1.87M
+12.83%
Jun 30, 2025
Managed Account Advisors LLC
13.77M
1.07%
-170.61K
-1.22%
Jun 30, 2025
BlackRock Financial Management, Inc.
15.63M
1.22%
+1.48M
+10.48%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Absolute Select Value ETF
4.89%
iShares U.S. Medical Devices ETF
4.4%
iShares Health Innovation Active ETF
4.26%
Cullen Enhanced Equity Income ETF
4.24%
USCF Dividend Income Fund
3.59%
JPMorgan Healthcare Leaders ETF
3.22%
Madison Dividend Value ETF
3.08%
Tema Heart & Health ETF
2.98%
Global X Aging Population ETF
2.98%
WisdomTree US AI Enhanced Value Fund
2.86%
查看更多
Absolute Select Value ETF
佔比4.89%
iShares U.S. Medical Devices ETF
佔比4.4%
iShares Health Innovation Active ETF
佔比4.26%
Cullen Enhanced Equity Income ETF
佔比4.24%
USCF Dividend Income Fund
佔比3.59%
JPMorgan Healthcare Leaders ETF
佔比3.22%
Madison Dividend Value ETF
佔比3.08%
Tema Heart & Health ETF
佔比2.98%
Global X Aging Population ETF
佔比2.98%
WisdomTree US AI Enhanced Value Fund
佔比2.86%

分紅派息

近5年累計派現 17.37B 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Aug 14, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 17, 2025 going ex on Sep 26, 2025 with reinvestment option
Sep 26, 2025
Oct 17, 2025
Sep 26, 2025
May 21, 2025
MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 11, 2025 going ex on Jun 27, 2025 with reinvestment option
Jun 27, 2025
Jul 11, 2025
Jun 27, 2025
Mar 06, 2025
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
查看更多

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Medtronic PLC的前五大股東是誰?

Medtronic PLC的前五大股東如下:
The Vanguard Group, Inc.
持有股份:126.32M
佔總股份比例:9.85%。
BlackRock Institutional Trust Company, N.A.
持有股份:67.84M
佔總股份比例:5.29%。
State Street Investment Management (US)
持有股份:59.83M
佔總股份比例:4.66%。
JP Morgan Asset Management
持有股份:26.31M
佔總股份比例:2.05%。
Capital Research Global Investors
持有股份:36.36M
佔總股份比例:2.83%。

Medtronic PLC的前三大股東類型是什麼?

Medtronic PLC 的前三大股東類型分別是:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)

有多少機構持有Medtronic PLC(MDT)的股份?

截至2025Q3,共有3723家機構持有Medtronic PLC的股份,合計持有的股份價值約為1.13B,占公司總股份的88.20% 。與2025Q2相比,機構持股有所增加,增幅為1.08%。

哪個業務部門對Medtronic PLC的收入貢獻最大?

在FY2026Q1,Cardiac Rhythm & Heart Failure業務部門對Medtronic PLC的收入貢獻最大,創收1.71B,占總收入的19.96% 。
KeyAI